Phase II trial of tamoxifen for progressive advanced urothelial carcinoma following prior chemotherapy.

Seth P. Lerner,Cora N. Sternberg,Mamoun Younes,Fabio Calabrò,Linda Cerbone,Aravind Chandrashekar,Carmen Mitchell,Steven S. Shen,Guru Sonpavde

Phase II trial of tamoxifen for progressive advanced urothelial carcinoma following prior chemotherapy.

2017

Seth P. Lerner
Cora N. Sternberg
Mamoun Younes
Fabio Calabrò
Linda Cerbone
Aravind Chandrashekar
Carmen Mitchell
Steven S. Shen
Guru Sonpavde

e15003 Background: Urothelial carcinoma (UC) expresses estrogen receptor (ER)-β, which increases with stage and grade. The selective estrogen receptor modulators, tamoxifen and raloxifene have disp...

Keywords:

Tamoxifen
Carcinoma
Selective estrogen receptor modulators
Cancer research
Pathology
Estrogen receptor
Raloxifene
Chemotherapy
Medicine
urothelial carcinoma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations